rsv merck - Search News

News

Merck's RSV shot for infants gets key approval

Merck’s RSV shot for infants gets key approval despite RFK Jr.’s panel shakeup

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who has previously made statements skeptical of vaccines,

Bloomberg · 3d

RFK Jr.’s Advisers Back Merck’s RSV Shot for Newborns

RFK Jr.’s vaccine panel endorsed Merck’s RSV shot for babies, easing fears that his stance might delay rollout.

STAT · 3d

CDC vaccine advisers recommend Merck’s RSV therapy for babies

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.

STAT2d

Pharmalittle: We’re reading about the gray market for obesity meds, an RSV drug recommendation, and more

Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...

RSV endangers thousands of Arizona babies a year. Will this shot help?

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

MPR2d

ACIP Recommends Enflonsia for RSV Prevention in Infants

Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results